The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
The use of chemotherapy for the treatment of cancer has improved outcomes in many types of cancer. Recent reserach has uncovered how and why cancer cells respond to chemotherapy. This reserach proposal will use this knowledge to evaluate a new approach to cancer treatment by targeting a process called cell cycle checkpoints. Specifically this proposal will evaluate the difference between normal cells and cancer cells and use imaging to examine response to these new treatments.
Improving The Assessment Of Brain Tumour Treatment Outcome Using 18F-FDOPA PET-MRI Fusion
Funder
National Health and Medical Research Council
Funding Amount
$660,666.00
Summary
The mortality rate within the first year of diagnosis for high-grade brain tumours is approximately 80%. A major factor contributing to poor outcome measures is the limitation of current neuroimaging techniques. In a novel approach we propose to combine the information available from MRI and PET images to better define the extent of the tumour and provide markers of early treatment response. This improved diagnostic information should improve survival rates.
Molecular Imaging To Advance Treatment Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$412,419.00
Summary
Molecular imaging using a scan technique called positron emission tomography, enables detection and measurement of specific pathological features of disease such as the amyloid plaques of Alzheimer’s disease. This project will develop this technology for other aspects of brain disorders including dementias, Parkinson’s disease, traumatic brain injury and schizophrenia and use it to assist development of therapies and improve clinical diagnosis nation wide.
Molecular Imaging Of Cancers With Copper And Zirconium Radiopharmaceuticals
Funder
National Health and Medical Research Council
Funding Amount
$466,475.00
Summary
This research aims to develop new imaging agents to assist in the diagnosis of breast cancer. This research will advance knowledge in the areas of chemistry, biotechnology and diagnostic imaging.
The Use Of Positron Emission Tomography (PET), Novel Immune And Microbiological Biomarkers To Improve The Diagnosis And Prognostication Of Giant Cell Arteritis
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Giant cell arteritis (GCA) is an inflammatory condition of blood vessels. Diagnosing the condition and predicting which patients will develop complications is challenging. Undiagnosed, a significant proportion of patients experience sudden onset, permanent blindness. Our study aims to improve the diagnosis and risk assessment of patients with suspected GCA by following a group of 65 patients for two years with serial scans, blood tests and clinical reviews.
A Motion Correction Technique For Accurate PET/CT Brain Imaging In Paediatric And Dementia Patients
Funder
National Health and Medical Research Council
Funding Amount
$190,450.00
Summary
PET-CT imaging is a vital tool in the diagnosis and management of patients with brain disorders including dementia, epilepsy and cancer. However images are often distorted by patient motion, particularly in demented and paediatric patients. The CI has recently developed a motion tracking and correction method to derive images nearly free of motion effects. This aim of this project is to evaluate its impact on image quality in a variety of patients referred for PET- CT brain investigations.